/content/dam/www/people-profile-photos/s/adrienne-shapiro/adrienne-shapiro-d.jpg
Shapiro
Adrienne E. Shapiro, MD, PhD

Adrienne E. Shapiro, MD, PhD

  • Assistant Professor, Immunology and Vaccine Development Program, Vaccine and Infectious Disease Division, Fred Hutch
  • Associate Medical Director, Seattle Vaccine Trials Unit, Fred Hutch
  • Assistant Professor, Department of Global Health, University of Washington
  • Assistant Professor, Allergy and Infectious Diseases, Department of Medicine, University of Washington

Background

Dr. Adrienne Shapiro is an infectious disease physician and global health scientist whose research focus is on tuberculosis, HIV/AIDS and COVID-19. Her priority is to address disparities in access to diagnosis, prevention and optimal treatment of these diseases, which are the leading causes of infectious disease deaths throughout the world. Dr. Shapiro collaborates with global health researchers in the U.S., South Africa and other regions on projects that include epidemiological studies, prevention strategies and clinical trials for vaccines and treatments. She also develops strategies for effective delivery of medical care in communities, both locally and throughout the world.

Attending Physician, Harborview Medical Center Infectious Diseases Service

Education

University of Washington, 2015-2019 Fellowship (Division of Allergy & Infectious Diseases)

University of California, San Francisco, 2013-2015 (Internal Medicine Residency)

Johns Hopkins School of Medicine, 2013, MD

Johns Hopkins Bloomberg School of Public Health, 2013. PhD (Epidemiology)

London School of Hygiene & Tropical Medicine, 2003, MSc (Control of Infectious Diseases)

Harvard College, 2002, AB (Biochemical Sciences)

Research Interests

Epidemiology, prevention, and treatment of infectious diseases

Tuberculosis

HIV

COVID-19

Vaccines

Clinical Trials

Clinical Expertise

HIV Primary Care

Advanced HIV Disease

Tuberculosis treatment and prevention

General Infectious Diseases

Find a Clinical Trial

Stories

All news
How Fred Hutch scientists tackle world’s top infectious killer, TB Expertise in immunology and biostatistics underpin foundational work in tuberculosis vaccines, biomarkers and pathology that could usher in a new era March 24, 2026
The benefits of HIV research? Let us count the ways HIV work has helped shape the FDA, provided drugs for other infections, changed health systems globally and more, say Fred Hutch experts November 28, 2025
Highlights of Fred Hutch science in 2021 From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives December 20, 2021